EU: Revised GMP-Annex 2 published - Details defined for biological products including ATMPs

31.01.2013
- Deadline for coming into operation: Jan. 31, 2013 -
 
On Sept. 9, 2012 the European Commission published the revised GMP Annex 2: Manufacture of Biological Medicinal Substances and Products for Human Use. You can find the document under
http://ec.europa.eu/health/files/eudralex/vol-4/vol4-an2__2012-06_en.pdf

The revised GMP Annex 2 contains additional guidance for the manufacture of biological medicinal products and specific guidance for certain types of products, e.g. ATMPs. This new document reflects latest legislation and comments received from industry on the previous draft version.


Back

HOTLINE

Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528
Mail

Events

  • 21.-22.04.2020
    Heidelberg: Handling Changes and Variations
    More
  • 05.05.2020
    Mannheim: Aktuelle Trends in der Qualitätskontrolle
    More
  • 13.-14.05.2020
    Prague: How to write the Quality Part of an IMPD
    More
Get all events



News

  • 25.03.2020
    New Deadline for Nitrosamine Impurities
    More
  • 24.03.2020
    News on Nitrosamine Impurities
    More
  • 23.03.2020
    In-house Trainings and Webinars
    More
Get all news
EU: New Variation System in force as of Jan 1, 2010. Filing of variations will be faster, easier, and more flexible. Have you considered that your Change Control System needs to be updated accordingly?
EU: Centralised Marketing Authorisation Procedure for ATMPs needed Have you already filed your application? The time clock is ticking. Transitional periods will be over soon.
This website uses cookies. By using the website you agree to the use of cookies. Privacy Policy X